ADULT SOLID NEOPLASM
Clinical trials for ADULT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new ADULT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for ADULT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial tests new drug combo for Tough-to-Treat cancers
Disease control OngoingThis early-stage study aims to find the safest and most effective dose of two drugs, ixabepilone and temsirolimus, when given together to adults with advanced solid tumors that have spread or cannot be surgically removed. The main goal is to understand the side effects and determ…
Matched conditions: ADULT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Experimental cancer vaccine teams up with immunotherapy in early trial
Disease control OngoingThis early-phase study is testing the safety of combining a new cancer vaccine with an existing immunotherapy drug (pembrolizumab) in patients with advanced solid tumors that have spread and stopped responding to standard treatments. The vaccine is designed to train the immune sy…
Matched conditions: ADULT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Scientists test new drug cocktail in fight against tough pancreatic cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of two or three drugs (vismodegib, erlotinib, and sometimes gemcitabine) in people with advanced pancreatic cancer or other solid tumors that cannot be removed by surgery. The goal is to see if blocking …
Matched conditions: ADULT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new drug duo in fight against advanced cancers
Disease control OngoingThis is an early-stage study to find the safest and most effective doses of two cancer drugs, erlotinib and irinotecan, when used together. It involves about 60 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to understand…
Matched conditions: ADULT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Early trial tests new drug combo for tough cancers
Knowledge-focused OngoingThis early-stage study is testing different dose schedules of the drug vorinostat when given with standard chemotherapy drugs (carboplatin or paclitaxel) in patients with advanced solid tumors. The main goal is to understand how the body processes the drugs, check for safety, and…
Matched conditions: ADULT SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC